<DOC>
	<DOC>NCT00634959</DOC>
	<brief_summary>To investigate the effects of food and dose regimen on the antiviral effects of Maraviroc (UK-427,857) in patients with human immunodeficiency virus (HIV)</brief_summary>
	<brief_title>Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus</brief_title>
	<detailed_description />
	<mesh_term>Maraviroc</mesh_term>
	<criteria>Asymptomatic HIV1 infected male and female patients Weight between 50 and 100kg and within the permitted range for their height Patients with virus that targets CCR5 receptor Patients with a CD4 count &lt;250 cells/mm3 or HIV viral load &lt;5000 copies/mL Patients whose HIV infection has been diagnosed less than 3 months prior to screening, or for who there is evidence of recent seroconversion Patients with acquired immunodeficiency syndrome (AIDS) or a previous AIDS diagnosis Patients who are taking or have taken antiretroviral drugs in the eight weeks prior to the study screening visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>HIV Infections</keyword>
	<keyword>Treatment Na√Øve</keyword>
</DOC>